title: Biosynthesis of type VI collagen by glioblastoma cells and possible function in cell invasion of three-dimensional matrices.
abstract: The biosynthesis of type VI collagen was studied in human glioblastoma cell line, U-87 MG. The effects of ascorbic acid on type VI collagen synthesis and secretion were investigated. After ascorbic acid treatment, type VI collagen in cell layers increased from 4.48% in control to 6.63% in the ascorbic acid treated cultures, an increase of 48%. The effect of ascorbic acid on type VI collagen synthesized by glioblastoma cells was lower than that reported for osteosarcoma cells (Engvall et al., 1986). The reason for these differences is still under investigation. The function of type VI collagen in glioblastoma cells is still unknown. We utilized the collagen gel system to elucidate the possible roles of type VI collagen in glioblastoma cells in vitro. Glioblastoma cells in collagen gels showed a stellate shape with long, branched processes in all directions. The strong positive reactivity of type VI collagen detected on cell bodies and cell processes by anti-type VI collagen antibody indicated that this specific collagen was associated with cell surfaces and processes, without releasing or diffusing into the gels. Type VI collagen was directly involved in the cell process extension. When living cells were treated with anti-type VI collagen antibody, a variation of cell morphology was observed. Instead of a stellate shape with processes, cells formed clusters without or with very short processes. These data suggest that type VI collagen, synthesized and secreted by glioblastoma cells, may play a role in tumor cell adhesion and spreading, and enhance cell process extension, penetration, and invasion into collagen gels.
authors.affiliation: Department of Anatomy and Cell Biology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.
authors.forename: J
authors.initials: J
authors.lastname: Han
authors.forename: J C
authors.initials: JC
authors.lastname: Daniel
mesh_terms: D000906:Antibodies / Q000494:pharmacology; D001187:Artificial Organs; D001205:Ascorbic Acid / Q000494:pharmacology; D001859:Bone Neoplasms / Q000378:metabolism* / Q000503:physiopathology; D001932:Brain Neoplasms / Q000378:metabolism* / Q000503:physiopathology; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology; D002462:Cell Membrane / Q000378:metabolism; D048430:Cell Shape / Q000187:drug effects / Q000502:physiology; D022081:Cell Surface Extensions / Q000187:drug effects / Q000378:metabolism; D024142:Collagen Type VI / Q000096:biosynthesis* / Q000187:drug effects / Q000378:metabolism; D005109:Extracellular Matrix / Q000378:metabolism*; D005782:Gels; D005909:Glioblastoma / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D008954:Models, Biological; D009361:Neoplasm Invasiveness / Q000503:physiopathology*; D012516:Osteosarcoma / Q000378:metabolism* / Q000503:physiopathology; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
chemical_list: D000906:Antibodies; D024142:Collagen Type VI; D005782:Gels; D001205:Ascorbic Acid